Question 1

What are the potential benefits of participating in this trial for my pneumonia?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia clinical trial (NCT04160260). Contact the study team or your healthcare provider for specific answers.

Question 2

How does omadacycline compare to other antibiotics I might take?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia clinical trial (NCT04160260). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia clinical trial (NCT04160260). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia clinical trial (NCT04160260). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia clinical trial (NCT04160260). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia clinical trial (NCT04160260). Contact the study team or your healthcare provider for specific answers.

What this study is about